Medical-tech News

Medical imaging co Paeion looks to raise $10m

Sunday, September 12th, 2010

by  Batya Feldman

Medical device company Paieon Medical is setting out to raise $10 million, in order to gear up for penetrating the US market. The company intends to make an initial public offering on the Tel Aviv Stock Exchange, or alternatively to raise the money from private investors. Paieon was founded in 2000 as a spin off from Vectop, which was acquired by Rada Electronic Industries Ltd. in 2005. The company is developing medical imaging devices for invasive cardiology, based on technology that was developed in the military and the defense industry. The company’s founder and CEO is Omer Barlev, an experienced entrepreneur in imaging and electro-optics, a former commander of Sayeret Matkal (the General Staff Reconnaissance Unit), and the son of the IDF’s eighth chief of staff, Haim Barlev. http://www.globes.co.il/serveen/globes/docview.asp?did=1000588062&fid=1725

Medical device start-up superDimension raises $24.8m

Sunday, September 12th, 2010

by Shiri Habib Valdhorn

Medical device start-up superDimension has raised $24.8 million, to reach a total of over $100 million raised since its establishment 15 years ago. According to IVC, the company has raised $109.4 million, including the current round. The company has developed minimally-invasive devices that enable the diagnosis and potentially the treatment of distal lung disease. A majority of the current funding, $15 million, is from a credit line from Oxford Finance, a US financial institution that specializes in life sciences funding. The company also raised $9.8 million from existing investors, which include Medica , Oxford Bioscience Parters, OrbiMed Advisors LLC, and Pitango Venture Capital. superDimension’s technology was originally developed for the toy industry – navigation for toy planes – but subsequently the firm decided to focus on the medical device market. http://www.globes.co.il/serveen/globes/docview.asp?did=1000587915&fid=1725

New Israeli treatment kills HIV cells

Tuesday, September 7th, 2010

by ISRAEL21c Staff 

The therapy, developed by scientists from the university’s Alexander Silberman Institute of Life Sciences and the Institute of Chemistry, destroys cells infected with HIV without damaging adjacent healthy cells. It is described in an article published last month in the scientific journal AIDS Research and Therapy. The new treatment fights HIV by causing infected cells to self-destruct. When the AIDS virus infects a cell, its DNA penetrates the cell, which then manufactures new HIV viruses that infect neighboring cells. http://www.israel21c.org/201009058318/health/new-israeli-treatment-kills-hiv-cells

Sialo advances with new dental implant

Thursday, September 2nd, 2010

by Koby Yeshayahou

Sialo Technology Israel Ltd. has completed development of its new dental implant and has begun building a prototype. The company also filed for a US patent for the implant, which if approved, will provide patent protection for up to 20 years. The new dental implant is adapted for insertion by Sialo’s proprietary direct line-of-sight dental endoscope, although the implant can be inserted without the endoscope. The implant can be used for the insertion of filling material into the jawbone, as well as for viewing insertion and treatment procedures. Average recovery time is three months. http://www.globes.co.il/serveen/globes/docview.asp?did=1000586221&fid=1725